PULMONX CORPORATION Increase (Decrease) in Accounts Receivable
PULMONX CORPORATION (LUNG) reported Increase (Decrease) in Accounts Receivable of $297.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- PULMONX CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $1.50M, a 23.03% increase year-over-year.
- PULMONX CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.20M, a 266.99% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$1.61M, a 192.25% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$1.41M, a 492.76% decline year-over-year.
- PULMONX CORPORATION increase (decrease) in accounts receivable for fiscal 2025 was -$1.07M, a 182.19% decline from fiscal 2024.
- PULMONX CORPORATION increase (decrease) in accounts receivable for fiscal 2024 was $1.31M, a 57.86% decline from fiscal 2023.
- PULMONX CORPORATION increase (decrease) in accounts receivable for fiscal 2023 was $3.10M, a 41.74% increase from fiscal 2022.
- PULMONX CORPORATION increase (decrease) in accounts receivable for fiscal 2022 was $2.19M, a 9.95% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $297.00K 10-Q · filed 2026-08-04 | -$1.31M derived: sum of 3 quarters · filed 2026-08-04 | -$2.72M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$1.20M 10-Q · filed 2026-05-04 | -$2.81M derived: sum of 2 quarters · filed 2026-05-04 | -$4.22M derived: sum of 3 quarters · filed 2026-05-04 | -$3.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$3.02M derived: sum of 2 quarters · filed 2026-03-10 | -$1.80M derived: sum of 3 quarters · filed 2026-08-04 | -$1.07M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$190.00K derived: sum of 2 quarters · filed 2026-08-04 | $531.00K 10-Q · filed 2025-11-12 | $2.27M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.94M 10-Q · filed 2026-08-04 | $3.68M derived: sum of 3 quarters · filed 2026-08-04 | $4.04M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $721.00K 10-Q · filed 2026-05-04 | $2.46M derived: sum of 2 quarters · filed 2026-05-04 | $2.82M derived: sum of 3 quarters · filed 2026-05-04 | $3.39M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.10M derived: sum of 2 quarters · filed 2026-03-10 | $2.67M derived: sum of 3 quarters · filed 2026-03-10 | $1.31M 10-K · filed 2026-03-10 |
| 2024-09-30 | $359.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $930.00K derived: sum of 2 quarters · filed 2025-11-12 | -$433.00K 10-Q · filed 2025-11-12 | $1.33M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $571.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$792.00K 10-Q · filed 2025-08-01 | $970.00K derived: sum of 3 quarters · filed 2025-08-01 | $2.13M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | -$1.36M 10-Q · filed 2025-05-02 | $399.00K derived: sum of 2 quarters · filed 2025-05-02 | $1.56M derived: sum of 3 quarters · filed 2025-05-02 | $2.27M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.92M derived: sum of 2 quarters · filed 2025-02-25 | $3.63M derived: sum of 3 quarters · filed 2025-02-25 | $3.10M 10-K · filed 2025-02-25 |
| 2023-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $1.87M derived: sum of 2 quarters · filed 2024-11-01 | $1.34M 10-Q · filed 2024-11-01 | $2.63M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $715.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $184.00K 10-Q · filed 2024-08-02 | $1.47M derived: sum of 3 quarters · filed 2024-08-02 | $1.30M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$531.00K 10-Q · filed 2024-05-03 | $753.00K derived: sum of 2 quarters · filed 2024-05-03 | $586.00K derived: sum of 3 quarters · filed 2024-05-03 | $1.38M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.12M derived: sum of 2 quarters · filed 2024-02-27 | $1.91M derived: sum of 3 quarters · filed 2024-02-27 | $2.19M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $629.00K derived: sum of 2 quarters · filed 2023-11-03 | $906.00K 10-Q · filed 2023-11-03 | $519.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $796.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.07M 10-Q · filed 2023-08-04 | $686.00K derived: sum of 3 quarters · filed 2023-08-04 | $773.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $277.00K 10-Q · filed 2023-05-08 | -$110.00K derived: sum of 2 quarters · filed 2023-05-08 | -$23.00K derived: sum of 3 quarters · filed 2023-05-08 | $1.70M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$300.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.42M derived: sum of 3 quarters · filed 2023-03-01 | $2.43M 10-K · filed 2023-03-01 |
| 2021-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.80M derived: sum of 2 quarters · filed 2022-11-08 | $2.82M 10-Q · filed 2022-11-08 | $1.70M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.73M 10-Q · filed 2022-08-08 | $1.61M derived: sum of 3 quarters · filed 2022-08-08 | $4.19M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $1.01M 10-Q · filed 2022-05-09 | -$107.00K derived: sum of 2 quarters · filed 2022-05-09 | $2.48M derived: sum of 3 quarters · filed 2022-05-09 | $469.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.46M derived: sum of 2 quarters · filed 2022-03-01 | -$545.00K derived: sum of 3 quarters · filed 2022-03-01 | -$1.46M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $576.00K derived: sum of 2 quarters · filed 2021-11-09 | -$336.00K 10-Q · filed 2021-11-09 | -$123.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$2.92M 10-Q · filed 2021-08-10 | -$2.71M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$912.00K 10-Q · filed 2021-05-12 | -$699.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $2.52M 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $2.31M 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $262.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |